ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Kal Minerals Corp

Kal Minerals Corp (KAL)

0.14
0.00
(0.00%)
Closed 02 December 8:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.14
Bid
0.135
Offer
0.40
Volume
-
0.00 Day's Range 0.00
0.14 52 Week Range 0.14
Previous Close
0.14
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

KAL Latest News

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, May 24 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drugs for the treatment of cancer and inflammatory diseases, announced today...

Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal

History of Atiprimod Appears in Genetic Engineering & Biotechnology News NEW YORK, May 15 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.140.140.1400CS
4000.140.140.1400CS
12000.140.140.1400CS
26000.140.140.1400CS
52000.140.140.1400CS
156000.140.140.1400CS
2600.015120.1250.160.0816480.12148515CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ACRG.A.UAcreage Holdings Inc
US$ 0.01
(100.00%)
1.84k
BEEBee Vectoring Technologies International Inc
$ 0.01
(100.00%)
156.54k
VTALJustera Health Ltd
$ 0.01
(100.00%)
20k
MINAMinas Metals Ltd
$ 0.01
(100.00%)
2.31k
FFF55 North Mining Inc
$ 0.01
(100.00%)
2k
MLKMMayo Lake Minerals Inc
$ 0.02
(-55.56%)
22.38k
CHGXChitogenX Inc
$ 0.005
(-50.00%)
215k
FNQFineqia International Inc
$ 0.005
(-50.00%)
69.39k
EOMEco Oro Minerals Corp
$ 0.005
(-50.00%)
7k
GPKGrand Peak Capital Corp
$ 0.10
(-50.00%)
1.5k
SPMTSpearmint Resources Inc
$ 0.02
(0.00%)
4.98M
QIMCQuebec Innovative Materials Corp
$ 0.135
(-6.90%)
1.79M
AIMLAl ML Innovations Inc
$ 0.105
(-4.55%)
1.78M
CACRKWG Resources Inc
$ 0.015
(0.00%)
1.78M
MILIMilitary Metals Corp
$ 0.39
(23.81%)
1.4M

Discussion

View Full Feed
Debunkinator Debunkinator 3 minutes ago
Time to bust a move $ASII--Lets rock.
ASII
Risk vs Reward Risk vs Reward 4 minutes ago
1.1 mil more sells than buys but its up .51 ?? 
Am I missing something ?
KULR
jimmybob jimmybob 4 minutes ago
$SQ PT raised to $120 from $90 at Bernstein - keeps Outperform rated
SQ
bb8675309 bb8675309 4 minutes ago
Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024

This year’s conference features over 600 industry experts and corporate leaders from more than 225 leading healthcare companies.

https://finance.yahoo.com/news/anavex-life-sciences
AVXL
Don jr Don jr 5 minutes ago
Voting is this week.

VANCOUVER, BC and WILMINGTON, Mass., Nov. 21, 2024 /CNW/ - Liberty Defense Holdings, Ltd. ("Liberty" or the "Company") (TSXV: SCAN) (OTCQB: LDDFF) (FRANKFURT: LD2), a leading technology provider of AI-based next generation detection solutions for concealed weapons
LDDFF
ddls ddls 5 minutes ago
Let's see if a doctor prescribes this junk.😎

Tik Tok Tik Tok Meanwhile down she goes.😭
BIEL
Dingbatt Dingbatt 6 minutes ago
Jaytee
everybody is loosing but so far we haven’t been sent to the abortion clinic because of Roe vs Wade and Chevron so maybe a Soros Wante a bee is going to the rendering plant with a Louie Vuitton purse instead this baby
RNVA
TrendTrade2016 TrendTrade2016 6 minutes ago
HOVR 91C
HOVR
StayHumble StayHumble 6 minutes ago
🇺🇸Hearing a MOASS takes $DJT to MARS🇺🇸wow🇺🇸🇺🇸
DJT
uranium-pinto-beans uranium-pinto-beans 6 minutes ago
AMC Entertainment reports 8.8M moviegoers during Thanksgiving period
AMC
nssrr5 nssrr5 6 minutes ago
Nice - and I have over 50,000 shares with an average PPS under 2. Future Bags of GOLD! I am not worried about a damn thing other than maybe adding more shares.

Good Luck to you HappyGlass!
TLRY
SilkRoad SilkRoad 7 minutes ago
I thought for sure we’d get a PR this morning. Well, there’s 4 more business days left in the week. Meh.
KBLB
uranium-pinto-beans uranium-pinto-beans 7 minutes ago
DAILY RECAP

BYD Co. ( $BYDDF) reported a 67.8% y/y increase in November vehicle sales, reaching 506,804 units compared to 301,903 last year. Year-to-date sales hit 3.76M units, up from 2.68M last year.

Gap ( $GAP) received an upgrade to overweight from neutral by JPMorg
BLCO BYD BYDDF
Hoskuld Hoskuld 8 minutes ago
IDK - if the OLE data is material - and if they had to wait for it to submit then it is - then they would have to release it to shareholders and prospective shareholders.
AVXL
uranium-pinto-beans uranium-pinto-beans 8 minutes ago
RCL
Royal Caribbean price target raised to $272 from $204 at Truist
Truist raised the firm's price target on Royal Caribbean to $272 from $204 and keeps a Buy rating on the shares as part of a broader research note on Cruise lines. The firm's recent discussions with senior executive
RCL
Investor2014 Investor2014 8 minutes ago
Nobody really knows and that includes catdaddy and me.
AVXL
uranium-pinto-beans uranium-pinto-beans 8 minutes ago
SQ
Block price target raised to $102 from $87 at Goldman Sachs
Goldman Sachs raised the firm's price target on Block to $102 from $87 and keeps a Buy rating on the shares. Since the election, the median payment technology stock in coverage has increased 18%, with higher beta growth
uranium-pinto-beans uranium-pinto-beans 8 minutes ago
RCL
Royal Caribbean price target raised to $272 from $204 at Truist
Truist raised the firm's price target on Royal Caribbean to $272 from $204 and keeps a Buy rating on the shares as part of a broader research note on Cruise lines. The firm's recent discussions with senior executive
RCL
MomsSpaghetti MomsSpaghetti 8 minutes ago
They believe in their people and their product... bullish
MNMD
MomsSpaghetti MomsSpaghetti 9 minutes ago
MindMed Announces New Employee Inducement Grants

https://ir.mindmed.co/news-events/press-releases/detail/165/mindmed-announces-new-employee-inducement-grants

Dec 02, 2024 7:00 am EST

NEW YORK--(BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD)
MNMD
uranium-pinto-beans uranium-pinto-beans 9 minutes ago
RCL
Royal Caribbean price target raised to $272 from $204 at Truist
Truist raised the firm's price target on Royal Caribbean to $272 from $204 and keeps a Buy rating on the shares as part of a broader research note on Cruise lines. The firm's recent discussions with senior executive
RCL
NioTurd NioTurd 9 minutes ago
someone wants to buy 15000 shares?
NB
Zadie420 Zadie420 10 minutes ago
You nailed it.
NWBO
Moonboy1 Moonboy1 10 minutes ago
Being careful with this one. It's the only one that hasn't done an offering yet. May be because they just regained compliance on the Nasdaq a month ago. But it's coming in my opinion.
QBTS
StayHumble StayHumble 10 minutes ago
Power2 the P1ayers✅24/7 interest here💹 💹 💹 💹
GME

Your Recent History

Delayed Upgrade Clock